American International Assurance Co. Ltd. Dec 11

  • ID: 2035107
  • December 2011
  • Region: Global, United States
  • Standard & Poors
1 of 3

Very strong competitive positions in some Asian markets Robust capitalization and high quality earnings Prudent and diverse investment profile given regulatory restriction in some markets Very strong financial flexibility Industry and investment risks associated with markets in which the company operates Enterprise risk management is less developed than international peers, but is still adequate The rating on American International Assurance Co. Ltd. (AIA) reflects our view of the insurer's core status to AIA Group Ltd. (not rated). AIA has a very strong competitive position in some insurance markets in Asia. Its robust financial profile, very strong financial flexibility as a listed entity, and prudent and diverse investment profile also support the ratings. Moderating these strengths are the risks associated with...

Companies mentioned in this report are: American International Assurance Co. Ltd.
Action: Review

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown
2 of 3

American International Assurance Co. Ltd.

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.